Par Drugs and Chemicals Limited (NSE:PAR)
India · Delayed Price · Currency is INR 101.33
-1.15 (-1.12%)
Aug 21, 2026, 3:29 PM IST
Par Drugs and Chemicals Market Cap
Par Drugs and Chemicals has a market cap or net worth of 1.25 billion as of August 21, 2026. Its market cap has increased by 2.35% in one year.
Market Cap
1.25B
Enterprise Value
828.40M
Revenue
1.09B
Ranking
n/a
PE Ratio
8.60
Stock Price
101.33
ChartMarket Cap Chart
Since May 16, 2019, Par Drugs and Chemicals's market cap has increased from 310.38M to 1.25B, an increase of 301.70%. That is a compound annual growth rate of 21.07%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 1.25B | 0.07% |
| Dec 31, 2025 | 1.25B | -49.09% |
| Dec 31, 2024 | 2.45B | -7.79% |
| Dec 29, 2023 | 2.65B | 42.80% |
| Dec 30, 2022 | 1.86B | -24.94% |
| Dec 31, 2021 | 2.48B | 451.37% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 16, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sigachi Industries | 11.58B |
| Amanta Healthcare | 6.40B |
| Bafna Pharmaceuticals | 5.62B |
| Valiant Laboratories | 4.98B |
| Nectar Lifesciences | 2.00B |
| Brooks Laboratories | 1.78B |
| Alpa Laboratories | 1.31B |
| Balaxi Pharmaceuticals | 1.23B |